🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 57 (from laksa121)

2. Crawled Status Check

Query:

Response:

{"found_url":"https:\/\/www.gilead.com\/","crawl_time":1776332879,"first_indexed_time":1375985357,"http_code":200,"src_unparsed":"com,gilead!www,\/ s443","src_root_hash":"703463787215412657","history_drop_reason":null,"meta_title":"Gilead Sciences","meta_descriptions":["Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation."],"attrs_boilerpipe_text":"Delivering\nTransformative Therapies\nand Advancing Health Equity \nThrough innovation, we’re helping to build a healthier world for all people.\nLearn More About Gilead\n25+\nMedicines Offered Globally\n53\nClinical Programs Across Virology, Oncology and Inflammation\n#1\nFunder of Philanthropic HIV Programs in the U.S.\nUsing Science to Improve the Lives of People and Communities\nWe invest in world-class science to combat the world's most serious diseases.\nExplore Science\nA Strong Pipeline Spanning Three Therapeutic Areas\nWe have a deep, diverse pipeline across Virology, Oncology and Inflammation.\nView Our Pipeline\nStories@Gilead\nFollow our journey to\ncreate a healthier world\nfor all people\nNo story to list\nLoading Results...\nScientific Innovation\nPutting Patients First in Metastatic Triple-Negative Breast Cancer Clinical Trials\nMarch 18, 2026\nView Stories@Gilead\nAccess and Health Equity\nChampioning HIV Support in Italy Through Community-Based Checkpoints\nJanuary 29, 2026\nView Stories@Gilead\nAccess and Health Equity\nGilead's Seat at the Table of Conversations Centered Around HIV\nDecember 4, 2025\nView Stories@Gilead\nScientific Innovation\nGilead's Commitment to Bridging the Unmet HIV Treatment Gap\nApril 8, 2026\nView Stories@Gilead\nScientific Innovation\nThe Unprecedented Role Manufacturing Innovation Played in Shaping Gilead’s Long-Acting HIV Prevention Therapy\nMarch 26, 2026\nView Stories@Gilead\nScientific Innovation\nPutting Patients First in Metastatic Triple-Negative Breast Cancer Clinical Trials\nMarch 18, 2026\nView Stories@Gilead\nAccess and Health Equity\nChampioning HIV Support in Italy Through Community-Based Checkpoints\nJanuary 29, 2026\nView Stories@Gilead\nAccess and Health Equity\nGilead's Seat at the Table of Conversations Centered Around HIV\nDecember 4, 2025\nView Stories@Gilead\nScientific Innovation\nGilead's Commitment to Bridging the Unmet HIV Treatment Gap\nApril 8, 2026\nView Stories@Gilead\nScientific Innovation\nThe Unprecedented Role Manufacturing Innovation Played in Shaping Gilead’s Long-Acting HIV Prevention Therapy\nMarch 26, 2026\nView Stories@Gilead\nScientific Innovation\nPutting Patients First in Metastatic Triple-Negative Breast Cancer Clinical Trials\nMarch 18, 2026\nView Stories@Gilead\nAn Inclusive Workplace Where We All Can Make an Impact\nGilead employees work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work.\nExplore Careers at Gilead\nNews\nSome of the content on this page is not intended for users outside the U.S.\nView News\nLoading Results...\nInvestors\nDriven by Purpose, Delivering\nLife-Changing Therapies","attrs_markdown":"[![All-Pages-Gilead-logo](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/89749f3b535e4eebb8ae07c8e9607b17?v=c1371898)](https:\/\/www.gilead.com\/ \"Image 1\")\n\n- [Science](https:\/\/www.gilead.com\/science)\n  - [Science](https:\/\/www.gilead.com\/science\/overview)\n  - [Therapeutic Areas](https:\/\/www.gilead.com\/science\/therapeutic-areas)\n    - [Therapeutic Areas](https:\/\/www.gilead.com\/science\/therapeutic-areas\/overview)\n    - [Virology](https:\/\/www.gilead.com\/science\/therapeutic-areas\/virology)\n      - [Virology](https:\/\/www.gilead.com\/science\/therapeutic-areas\/virology\/overview)\n      - [HIV](https:\/\/www.gilead.com\/science\/therapeutic-areas\/virology\/hiv)\n      - [Viral Hepatitis](https:\/\/www.gilead.com\/science\/therapeutic-areas\/virology\/viral-hepatitis)\n      - [Neglected & Emerging Viruses and Pandemic Preparedness](https:\/\/www.gilead.com\/science\/therapeutic-areas\/virology\/neglected-and-emerging-viruses-and-pandemic-preparedness)\n    - [Oncology](https:\/\/www.gilead.com\/science\/therapeutic-areas\/oncology)\n    - [Inflammation](https:\/\/www.gilead.com\/science\/therapeutic-areas\/inflammation)\n  - [Pipeline](https:\/\/www.gilead.com\/science\/pipeline)\n  - [Research](https:\/\/www.gilead.com\/science\/research)\n    - [Research](https:\/\/www.gilead.com\/science\/research\/overview)\n    - [Our R\\&D Approach](https:\/\/www.gilead.com\/science\/research\/our-r-and-d-approach)\n    - [Research Funding Programs](https:\/\/www.gilead.com\/science\/research\/research-funding-programs)\n      - [Research Funding Programs](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/overview)\n      - [Research Scholars Program](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/research-scholars-program)\n      - [External-Sponsored Research](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/external-sponsored-research)\n        - [External-Sponsored Research](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/external-sponsored-research\/overview)\n        - [Virology RFP Opportunities](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/external-sponsored-research\/virology-rfp-opportunities)\n        - [Oncology RFP Opportunities](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/external-sponsored-research\/oncology-rfp-opportunities)\n        - [Inflammation RFP Opportunities](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/external-sponsored-research\/inflammation-rfp-opportunities)\n      - [Community-Based Participatory Research](https:\/\/www.gilead.com\/science\/research\/research-funding-programs\/community-based-participatory-research)\n    - [Research Publications](https:\/\/www.gilead.com\/science\/research\/research-publications)\n  - [Clinical Trials](https:\/\/www.gilead.com\/science\/clinical-trials)\n  - [Diversity in Clinical Trials](https:\/\/www.gilead.com\/science\/diversity-in-clinical-trials)\n- [Medicines](https:\/\/www.gilead.com\/medicines)\n  - [Medicines](https:\/\/www.gilead.com\/medicines\/overview)\n  - [Patient Safety](https:\/\/www.gilead.com\/medicines\/patient-safety)\n    - [Patient Safety](https:\/\/www.gilead.com\/medicines\/patient-safety\/overview)\n    - [Anti-Counterfeiting](https:\/\/www.gilead.com\/medicines\/patient-safety\/anti-counterfeiting)\n    - [Consumer Product Safety](https:\/\/www.gilead.com\/medicines\/patient-safety\/consumer-product-safety)\n    - [Report an Adverse Event](https:\/\/www.gilead.com\/medicines\/patient-safety\/report-an-adverse-event)\n  - [Medication Access](https:\/\/www.gilead.com\/medicines\/medication-access)\n    - [Medication Access](https:\/\/www.gilead.com\/medicines\/medication-access\/overview)\n    - [U.S. Patient Access](https:\/\/www.gilead.com\/medicines\/medication-access\/us-patient-access)\n    - [Managed Access](https:\/\/www.gilead.com\/medicines\/medication-access\/managed-access)\n  - [Authorized Distributors](https:\/\/www.gilead.com\/medicines\/authorized-distributors)\n- [Responsibility](https:\/\/www.gilead.com\/responsibility)\n  - [Responsibility](https:\/\/www.gilead.com\/responsibility\/overview)\n  - [ESG](https:\/\/www.gilead.com\/responsibility\/esg)\n    - [ESG](https:\/\/www.gilead.com\/responsibility\/esg\/overview)\n    - [ESG Performance](https:\/\/www.gilead.com\/responsibility\/esg\/esg-performance)\n    - [ESG Focus Areas](https:\/\/www.gilead.com\/responsibility\/esg\/esg-focus-areas)\n    - [ESG Frameworks and Reporting](https:\/\/www.gilead.com\/responsibility\/esg\/esg-frameworks-and-reporting)\n  - [Sustainability](https:\/\/www.gilead.com\/responsibility\/sustainability)\n    - [Sustainability](https:\/\/www.gilead.com\/responsibility\/sustainability\/overview)\n    - [Sustainability Focus Areas](https:\/\/www.gilead.com\/responsibility\/sustainability\/sustainability-focus-areas)\n  - [Health Equity](https:\/\/www.gilead.com\/responsibility\/health-equity)\n  - [Giving@Gilead](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead)\n    - [Giving@Gilead](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/overview)\n    - [Corporate Giving](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving)\n      - [Corporate Giving](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/overview)\n      - [Strategic Initiatives](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives)\n        - [Strategic Initiatives](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/overview)\n        - [All4Liver](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/all4liver)\n        - [Asia Pacific Rainbow Grant](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/asia-pacific-rainbow-grant)\n        - [COMPASS Initiative](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/compass-initiative)\n        - [HepConnect](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/hepconnect)\n        - [HIV Age Positively](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/hiv-age-positively)\n        - [RADIAN](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/radian)\n        - [Setting the P.A.C.E.- Prevention, Arts and Advocacy, Community, Education](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/setting-the-pace)\n        - [Gilead Oncology Grant](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/gilead-oncology-grant)\n        - [Toward Health Equity for Black People Impacted by TNBC](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/toward-health-equity-for-black-people-impacted-by-tnbc)\n        - [TRANScend](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/transcend)\n        - [Zeroing In: Ending the HIV Epidemic](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/strategic-initiatives\/zeroing-in-ending-the-hiv-epidemic)\n      - [How to Apply for Funding](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding)\n        - [How to Apply for Funding](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/overview)\n        - [Giving in Africa](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/giving-in-africa)\n        - [Giving in Asia](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/giving-in-asia)\n        - [Giving in Australia](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/giving-in-australia)\n        - [Giving in Europe & the Middle East](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/giving-in-europe-and-the-middle-east)\n        - [Giving in Latin America & the Caribbean](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/giving-in-latin-america-and-the-caribbean)\n        - [Giving in North America](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/giving-in-north-america)\n        - [Terms & Conditions](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/terms-and-conditions)\n        - [FAQs](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/corporate-giving\/how-to-apply-for-funding\/faqs)\n    - [Gilead Foundation](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/gilead-foundation)\n      - [Gilead Foundation](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/gilead-foundation\/overview)\n      - [Creating Possible Fund](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/gilead-foundation\/creating-possible-fund)\n      - [Building Community Donations](https:\/\/www.gilead.com\/responsibility\/giving-at-gilead\/gilead-foundation\/building-community-donations)\n  - [Global Health and Access](https:\/\/www.gilead.com\/responsibility\/global-health-and-access)\n    - [Global Health and Access](https:\/\/www.gilead.com\/responsibility\/global-health-and-access\/overview)\n    - [FOCUS](https:\/\/www.gilead.com\/responsibility\/global-health-and-access\/focus)\n    - [Access in Low- and Middle-Income Countries](https:\/\/www.gilead.com\/responsibility\/global-health-and-access\/access-in-low--and-middle-income-countries)\n      - [Access in Low- and Middle-Income Countries](https:\/\/www.gilead.com\/responsibility\/global-health-and-access\/access-in-low--and-middle-income-countries\/overview)\n      - [Access Strategy for Long-Acting PrEP](https:\/\/www.gilead.com\/responsibility\/global-health-and-access\/access-in-low--and-middle-income-countries\/access-strategy-for-long-acting-prep)\n      - [Invasive Fungal Infections](https:\/\/www.gilead.com\/responsibility\/global-health-and-access\/access-in-low--and-middle-income-countries\/invasive-fungal-infection)\n      - [Access Partnerships](https:\/\/www.gilead.com\/responsibility\/global-health-and-access\/access-in-low--and-middle-income-countries\/access-partnerships)\n  - [Inclusion and Diversity](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity)\n    - [Inclusion and Diversity](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/overview)\n    - [Employee Resource Groups](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups)\n      - [Employee Resource Groups](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/overview)\n      - [ADAPT](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/adapt)\n      - [GAIN](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/gain)\n      - [Gileados](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/gileados)\n      - [GLOBE](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/globe)\n      - [GVET](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/gvet)\n      - [Pride Alliance](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/pride-alliance)\n      - [Women at Gilead](https:\/\/www.gilead.com\/responsibility\/inclusion-and-diversity\/employee-resource-groups\/women-at-gilead)\n  - [Medical Education](https:\/\/www.gilead.com\/responsibility\/medical-education)\n- [Stories](https:\/\/www.gilead.com\/stories)\n- [Company](https:\/\/www.gilead.com\/company)\n  - [Company](https:\/\/www.gilead.com\/company\/overview)\n  - [Leadership](https:\/\/www.gilead.com\/company\/leadership)\n    - [View All Leaders](https:\/\/www.gilead.com\/company\/leadership\/overview)\n    - [Daniel O’Day](https:\/\/www.gilead.com\/company\/leadership\/daniel-oday)\n    - [Andrew Dickinson](https:\/\/www.gilead.com\/company\/leadership\/andrew-dickinson)\n    - [Stacey Ma](https:\/\/www.gilead.com\/company\/leadership\/stacey-ma)\n    - [Dietmar Berger, MD, PhD](https:\/\/www.gilead.com\/company\/leadership\/dietmar-berger)\n    - [Flavius Martin, MD](https:\/\/www.gilead.com\/company\/leadership\/flavius-martin)\n    - [Jyoti Mehra](https:\/\/www.gilead.com\/company\/leadership\/jyoti-mehra)\n    - [Johanna Mercier](https:\/\/www.gilead.com\/company\/leadership\/johanna-mercier)\n    - [Cindy Perettie](https:\/\/www.gilead.com\/company\/leadership\/cindy-perettie)\n    - [Keeley Cain Wettan](https:\/\/www.gilead.com\/company\/leadership\/keeley-wettan)\n  - [Board of Directors](https:\/\/www.gilead.com\/company\/board-of-directors)\n    - [View All Directors](https:\/\/www.gilead.com\/company\/board-of-directors\/overview)\n    - [Daniel O’Day](https:\/\/www.gilead.com\/company\/board-of-directors\/daniel-oday)\n    - [Jacqueline K. Barton, PhD](https:\/\/www.gilead.com\/company\/board-of-directors\/jacqueline-barton)\n    - [Jeffrey A. Bluestone, PhD](https:\/\/www.gilead.com\/company\/board-of-directors\/jeffrey-bluestone)\n    - [Sandra J. Horning, MD](https:\/\/www.gilead.com\/company\/board-of-directors\/sandra-horning)\n    - [Kelly A. Kramer](https:\/\/www.gilead.com\/company\/board-of-directors\/kelly-kramer)\n    - [Ted W. Love, MD](https:\/\/www.gilead.com\/company\/board-of-directors\/ted-love)\n    - [Harish Manwani](https:\/\/www.gilead.com\/company\/board-of-directors\/harish-manwani)\n    - [Javier J. Rodriguez](https:\/\/www.gilead.com\/company\/board-of-directors\/javier-rodriguez)\n    - [Anthony Welters](https:\/\/www.gilead.com\/company\/board-of-directors\/anthony-welters)\n  - [Board Governance and Committees](https:\/\/www.gilead.com\/company\/board-governance-and-committees)\n  - [Media](https:\/\/www.gilead.com\/company\/media)\n  - [Ethics and Compliance](https:\/\/www.gilead.com\/company\/ethics-and-compliance)\n  - [Policies and Procedures](https:\/\/www.gilead.com\/company\/policies-and-procedures)\n    - [Policies and Procedures](https:\/\/www.gilead.com\/company\/policies-and-procedures\/overview)\n    - [AI Principles](https:\/\/www.gilead.com\/company\/policies-and-procedures\/ai-principles)\n  - [Disclosures](https:\/\/www.gilead.com\/company\/disclosures)\n  - [U.S. Public Policy Engagement](https:\/\/www.gilead.com\/company\/us-public-policy-engagement)\n    - [U.S. Public Policy Engagement](https:\/\/www.gilead.com\/company\/us-public-policy-engagement\/overview)\n    - [Political Contributions Archives](https:\/\/www.gilead.com\/company\/us-public-policy-engagement\/political-contributions-archives)\n  - [Investing in the U.S.](https:\/\/www.gilead.com\/company\/investing-in-the-us)\n  - [Supplier Information](https:\/\/www.gilead.com\/company\/supplier-information)\n    - [Supplier Information](https:\/\/www.gilead.com\/company\/supplier-information\/overview)\n    - [Supplier Enablement Resources: SAP Ariba](https:\/\/www.gilead.com\/company\/supplier-information\/supplier-enablement-resources-sap-ariba)\n    - [Supplier Inclusion](https:\/\/www.gilead.com\/company\/supplier-information\/supplier-inclusion)\n  - [Annual Impact Reports](https:\/\/www.gilead.com\/company\/annual-impact-reports)\n  - [Awards and Recognition](https:\/\/www.gilead.com\/company\/awards-and-recognition)\n  - [U.S. Locations](https:\/\/www.gilead.com\/company\/us-locations)\n- [Careers](https:\/\/www.gilead.com\/careers)\n  - [Careers](https:\/\/www.gilead.com\/careers\/overview)\n  - [Life at Gilead](https:\/\/www.gilead.com\/careers\/life-at-gilead)\n    - [Life at Gilead](https:\/\/www.gilead.com\/careers\/life-at-gilead\/overview)\n    - [Inclusion and Diversity in Hiring](https:\/\/www.gilead.com\/careers\/life-at-gilead\/inclusion-and-diversity-in-hiring)\n  - [Opportunities](https:\/\/www.gilead.com\/careers\/opportunities)\n    - [Opportunities](https:\/\/www.gilead.com\/careers\/opportunities\/overview)\n    - [Early Career Opportunities](https:\/\/www.gilead.com\/careers\/opportunities\/early-career-opportunities)\n      - [Early Career Opportunities](https:\/\/www.gilead.com\/careers\/opportunities\/early-career-opportunities\/overview)\n      - [Gilead Internship Program](https:\/\/www.gilead.com\/careers\/opportunities\/early-career-opportunities\/gilead-internship-program)\n      - [Postdoctoral fellowships](https:\/\/www.gilead.com\/careers\/opportunities\/early-career-opportunities\/postdoctoral-fellowships)\n  - [Global Workforce](https:\/\/www.gilead.com\/careers\/global-workforce)\n\n- [Media](https:\/\/www.gilead.com\/media)\n- [Investors](https:\/\/investors.gilead.com\/)\n\nSearch\n\n```\n\n```\nSearch\n\nHamber\n\n![Gilead Logo](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/c77b5bddc2524cd1bcfe0d0d1288027f?v=a5ef68f5)\n\n# CREATING A HEALTHIER WORLD FOR ALL PEOPLE\n##### We’re honored to be recognized for advancing health around the world—driven by breakthrough science, a culture where everyone belongs, and partnerships rooted in the communities we serve.  [Learn more](https:\/\/www.gilead.com\/company\/awards-and-recognition).\n\n![People working at Lab](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/4c4d88f08457464a9ab7f2a5cbd22d5b?v=9fbe234a)![Gilead\\_Home\\_Banner\\_Dec\\_15\\_2025\\_Mobile.png](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/db6c8fd7667b4799ad2246fe0c06955d?v=87130b38)\n\n## Delivering **Transformative Therapies** and Advancing Health Equity\nThrough innovation, we’re helping to build a healthier world for all people.\n\n[Learn More About Gilead](https:\/\/www.gilead.com\/company)\n\n![Medicines Offered Globally ](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/7457d41053dd4f9fae97c0e4ff93270c?v=400f31d9)\n\n25+\n\nMedicines Offered Globally\n\n![HIV-and-Viral-Hepatitis](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/6d837fdd76624d5bb0e1f021be9e4734?v=6bddf3f9)\n\n53\n\nClinical Programs Across Virology, Oncology and Inflammation\n\n![Philanthropic Funder of HIV-Related Programs ](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/709f9f9997a14c8daa1d59176cf8f393?v=9636f0c8)\n\n\\#1\n\nFunder of Philanthropic HIV Programs in the U.S.\n\n![Four Gilead researchers in a lab.](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/bb257175bfae4bf88be1cd7439fa619f?v=b60cb4d9)![Four Gilead researchers in a lab.](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/3a35452a55a14b0099fe5dec989d4609?v=559e1037)\n\n## Using Science to Improve the Lives of People and Communities\nWe invest in world-class science to combat the world's most serious diseases.\n\n[Explore Science](https:\/\/www.gilead.com\/science)\n\n## A Strong Pipeline Spanning Three Therapeutic Areas\nWe have a deep, diverse pipeline across Virology, Oncology and Inflammation.\n\n[View Our Pipeline](https:\/\/www.gilead.com\/science\/pipeline)\n\n![A Gilead scientist smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/78bb07c0feba4a1ba3d0402569b69927?v=e51d4bc1)![A Gilead scientist smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/7c378c48a4c641bf8f5c7917d02e5327?v=1228dce1)\n\n[Virology ![Virology logo](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/a377511be5e34ac784b5acd7139ed0e5?v=32be3eef)](https:\/\/www.gilead.com\/science\/therapeutic-areas\/virology)\n\n[Oncology ![Oncology icon](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/bb4128c460f64f5aadded9bf7c04b770?v=97659d8e)](https:\/\/www.gilead.com\/science\/therapeutic-areas\/oncology)\n\n[Inflammation ![Inflammation icon](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/01b274cab814448c9b37a3cd6d41285a?v=2c54e11c)](https:\/\/www.gilead.com\/science\/therapeutic-areas\/inflammation)\n\n[View All Therapeutic Areas](https:\/\/www.gilead.com\/science\/therapeutic-areas)\n\nStories@Gilead\n\n**Follow our journey to create a healthier world for all people**\n\nNo story to list\n\nLoading Results...\n\n[View Stories@Gilead](https:\/\/www.gilead.com\/stories)\n\n## An Inclusive Workplace Where We All Can Make an Impact\nGilead employees work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work.\n\n[Explore Careers at Gilead](https:\/\/www.gilead.com\/careers)\n\n![Five people standing and smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/5beee38dbec7460581db202870c4950f?v=f24d33e4)![Five people standing and smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/cef297623ee04153bd980cb3e81ea518?v=47c946dd)\n\n## News\n*Some of the content on this page is not intended for users outside the U.S.*\n\n[View News](https:\/\/www.gilead.com\/news)\n\nLoading Results...\n\n**Investors**\n\n## Driven by Purpose, Delivering    **Life-Changing Therapies**\n### Resources for Investors\n[Investor Relations](https:\/\/investors.gilead.com\/overview\/default.aspx)\n\n[Events and Presentations](https:\/\/investors.gilead.com\/events-and-presentations\/default.aspx)\n\n[Stock Information](https:\/\/investors.gilead.com\/stock-info\/default.aspx)\n\n![a Gilead building](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/8b602d133f9a49908203ac4dfd533e9b?v=6bd18196)![Gilead Building](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/c139780057a54567a3b422751412d78d?v=02306872)\n\n![All-Pages-Gilead-logo](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/89749f3b535e4eebb8ae07c8e9607b17?v=bf06f14e)\n\nThis is our global website, intended for visitors seeking information on Gilead’s worldwide business. Some content on this site is not intended for people outside the United States. Visit our [Global Operations](https:\/\/www.gilead.com\/global-operations) page for links to our international corporate websites.\n\n### QUICK LINKS\n- [Investors](https:\/\/investors.gilead.com\/overview\/default.aspx)\n- [Find a Trial](https:\/\/www.gileadclinicaltrials.com\/)\n- [Pipeline](https:\/\/www.gilead.com\/science\/pipeline)\n- [Search for Jobs](https:\/\/gilead.yello.co\/job_boards\/v42vD4vKxb3AkKvV93YsrQ)\n- [News](https:\/\/www.gilead.com\/news)\n- [Stories@Gilead](https:\/\/www.gilead.com\/stories)\n\n### GET IN TOUCH\n- [Contact Us](https:\/\/www.gilead.com\/contact-us)\n- [Report an Adverse Event](https:\/\/www.gilead.com\/contact-us\/report-an-adverse-event)\n- [Medical Information](https:\/\/www.askgileadmedical.com\/)\n- [Partnership Request](https:\/\/www.gilead.com\/contact-us\/partnership-request)\n\n### LEGAL\n- [Modern Slavery Act Statement](https:\/\/www.gilead.com\/-\/media\/files\/pdfs\/company\/policies-and-disclosures\/modern-slavery-statement.pdf)\n- [Public Policy Engagement](https:\/\/www.gilead.com\/company\/us-public-policy-engagement)\n- [Social Media Guidelines](https:\/\/www.gilead.com\/social-media-guidelines)\n- [Privacy Statement](https:\/\/www.gilead.com\/privacy-statements)\n- [Consumer Health Data Privacy Policy](https:\/\/www.gilead.com\/privacy-statements\/consumer-health-data-privacy-policy)\n- [Terms of Use](https:\/\/www.gilead.com\/terms-of-use)\n- [Cookie Statement](https:\/\/www.gilead.com\/cookie-statement)\n***\n© 1996-2026 Gilead Sciences, Inc. All rights reserved. [Global Operations](https:\/\/www.gilead.com\/global-operations)  [Sitemap](https:\/\/www.gilead.com\/sitemap)","attrs_readable_markdown":"## Delivering **Transformative Therapies** and Advancing Health Equity\nThrough innovation, we’re helping to build a healthier world for all people.\n\n[Learn More About Gilead](https:\/\/www.gilead.com\/company)\n\n![Medicines Offered Globally ](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/7457d41053dd4f9fae97c0e4ff93270c?v=400f31d9)\n\n25+\n\nMedicines Offered Globally\n\n![HIV-and-Viral-Hepatitis](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/6d837fdd76624d5bb0e1f021be9e4734?v=6bddf3f9)\n\n53\n\nClinical Programs Across Virology, Oncology and Inflammation\n\n![Philanthropic Funder of HIV-Related Programs ](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/709f9f9997a14c8daa1d59176cf8f393?v=9636f0c8)\n\n\\#1\n\nFunder of Philanthropic HIV Programs in the U.S.\n\n![Four Gilead researchers in a lab.](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/bb257175bfae4bf88be1cd7439fa619f?v=b60cb4d9)![Four Gilead researchers in a lab.](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/3a35452a55a14b0099fe5dec989d4609?v=559e1037)\n\n## Using Science to Improve the Lives of People and Communities\nWe invest in world-class science to combat the world's most serious diseases.\n\n[Explore Science](https:\/\/www.gilead.com\/science)\n\n## A Strong Pipeline Spanning Three Therapeutic Areas\nWe have a deep, diverse pipeline across Virology, Oncology and Inflammation.\n\n[View Our Pipeline](https:\/\/www.gilead.com\/science\/pipeline)\n\n![A Gilead scientist smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/78bb07c0feba4a1ba3d0402569b69927?v=e51d4bc1)![A Gilead scientist smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/7c378c48a4c641bf8f5c7917d02e5327?v=1228dce1)\n\nStories@Gilead\n\n**Follow our journey to create a healthier world for all people**\n\nNo story to list\n\nLoading Results...\n\n## An Inclusive Workplace Where We All Can Make an Impact\nGilead employees work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work.\n\n[Explore Careers at Gilead](https:\/\/www.gilead.com\/careers)\n\n![Five people standing and smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/5beee38dbec7460581db202870c4950f?v=f24d33e4)![Five people standing and smiling](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/cef297623ee04153bd980cb3e81ea518?v=47c946dd)\n\n## News\n*Some of the content on this page is not intended for users outside the U.S.*\n\n[View News](https:\/\/www.gilead.com\/news)\n\nLoading Results...\n\n**Investors**\n\n## Driven by Purpose, Delivering    **Life-Changing Therapies**\n\n![a Gilead building](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/8b602d133f9a49908203ac4dfd533e9b?v=6bd18196)![Gilead Building](https:\/\/gilead.stylelabs.cloud\/api\/public\/content\/c139780057a54567a3b422751412d78d?v=02306872)","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

1 day ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.gilead.com/
Last Crawled	2026-04-16 09:47:59 (1 day ago)
First Indexed	2013-08-08 18:09:17 (12 years ago)
HTTP Status Code	200
Meta Title	Gilead Sciences
Meta Description	Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
Meta Canonical	null
Boilerpipe Text	Delivering Transformative Therapies and Advancing Health Equity Through innovation, we’re helping to build a healthier world for all people. Learn More About Gilead 25+ Medicines Offered Globally 53 Clinical Programs Across Virology, Oncology and Inflammation #1 Funder of Philanthropic HIV Programs in the U.S. Using Science to Improve the Lives of People and Communities We invest in world-class science to combat the world's most serious diseases. Explore Science A Strong Pipeline Spanning Three Therapeutic Areas We have a deep, diverse pipeline across Virology, Oncology and Inflammation. View Our Pipeline Stories@Gilead Follow our journey to create a healthier world for all people No story to list Loading Results... Scientific Innovation Putting Patients First in Metastatic Triple-Negative Breast Cancer Clinical Trials March 18, 2026 View Stories@Gilead Access and Health Equity Championing HIV Support in Italy Through Community-Based Checkpoints January 29, 2026 View Stories@Gilead Access and Health Equity Gilead's Seat at the Table of Conversations Centered Around HIV December 4, 2025 View Stories@Gilead Scientific Innovation Gilead's Commitment to Bridging the Unmet HIV Treatment Gap April 8, 2026 View Stories@Gilead Scientific Innovation The Unprecedented Role Manufacturing Innovation Played in Shaping Gilead’s Long-Acting HIV Prevention Therapy March 26, 2026 View Stories@Gilead Scientific Innovation Putting Patients First in Metastatic Triple-Negative Breast Cancer Clinical Trials March 18, 2026 View Stories@Gilead Access and Health Equity Championing HIV Support in Italy Through Community-Based Checkpoints January 29, 2026 View Stories@Gilead Access and Health Equity Gilead's Seat at the Table of Conversations Centered Around HIV December 4, 2025 View Stories@Gilead Scientific Innovation Gilead's Commitment to Bridging the Unmet HIV Treatment Gap April 8, 2026 View Stories@Gilead Scientific Innovation The Unprecedented Role Manufacturing Innovation Played in Shaping Gilead’s Long-Acting HIV Prevention Therapy March 26, 2026 View Stories@Gilead Scientific Innovation Putting Patients First in Metastatic Triple-Negative Breast Cancer Clinical Trials March 18, 2026 View Stories@Gilead An Inclusive Workplace Where We All Can Make an Impact Gilead employees work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work. Explore Careers at Gilead News Some of the content on this page is not intended for users outside the U.S. View News Loading Results... Investors Driven by Purpose, Delivering Life-Changing Therapies
Markdown	[![All-Pages-Gilead-logo](https://gilead.stylelabs.cloud/api/public/content/89749f3b535e4eebb8ae07c8e9607b17?v=c1371898)](https://www.gilead.com/ "Image 1") - [Science](https://www.gilead.com/science) - [Science](https://www.gilead.com/science/overview) - [Therapeutic Areas](https://www.gilead.com/science/therapeutic-areas) - [Therapeutic Areas](https://www.gilead.com/science/therapeutic-areas/overview) - [Virology](https://www.gilead.com/science/therapeutic-areas/virology) - [Virology](https://www.gilead.com/science/therapeutic-areas/virology/overview) - [HIV](https://www.gilead.com/science/therapeutic-areas/virology/hiv) - [Viral Hepatitis](https://www.gilead.com/science/therapeutic-areas/virology/viral-hepatitis) - [Neglected & Emerging Viruses and Pandemic Preparedness](https://www.gilead.com/science/therapeutic-areas/virology/neglected-and-emerging-viruses-and-pandemic-preparedness) - [Oncology](https://www.gilead.com/science/therapeutic-areas/oncology) - [Inflammation](https://www.gilead.com/science/therapeutic-areas/inflammation) - [Pipeline](https://www.gilead.com/science/pipeline) - [Research](https://www.gilead.com/science/research) - [Research](https://www.gilead.com/science/research/overview) - [Our R\&D Approach](https://www.gilead.com/science/research/our-r-and-d-approach) - [Research Funding Programs](https://www.gilead.com/science/research/research-funding-programs) - [Research Funding Programs](https://www.gilead.com/science/research/research-funding-programs/overview) - [Research Scholars Program](https://www.gilead.com/science/research/research-funding-programs/research-scholars-program) - [External-Sponsored Research](https://www.gilead.com/science/research/research-funding-programs/external-sponsored-research) - [External-Sponsored Research](https://www.gilead.com/science/research/research-funding-programs/external-sponsored-research/overview) - [Virology RFP Opportunities](https://www.gilead.com/science/research/research-funding-programs/external-sponsored-research/virology-rfp-opportunities) - [Oncology RFP Opportunities](https://www.gilead.com/science/research/research-funding-programs/external-sponsored-research/oncology-rfp-opportunities) - [Inflammation RFP Opportunities](https://www.gilead.com/science/research/research-funding-programs/external-sponsored-research/inflammation-rfp-opportunities) - [Community-Based Participatory Research](https://www.gilead.com/science/research/research-funding-programs/community-based-participatory-research) - [Research Publications](https://www.gilead.com/science/research/research-publications) - [Clinical Trials](https://www.gilead.com/science/clinical-trials) - [Diversity in Clinical Trials](https://www.gilead.com/science/diversity-in-clinical-trials) - [Medicines](https://www.gilead.com/medicines) - [Medicines](https://www.gilead.com/medicines/overview) - [Patient Safety](https://www.gilead.com/medicines/patient-safety) - [Patient Safety](https://www.gilead.com/medicines/patient-safety/overview) - [Anti-Counterfeiting](https://www.gilead.com/medicines/patient-safety/anti-counterfeiting) - [Consumer Product Safety](https://www.gilead.com/medicines/patient-safety/consumer-product-safety) - [Report an Adverse Event](https://www.gilead.com/medicines/patient-safety/report-an-adverse-event) - [Medication Access](https://www.gilead.com/medicines/medication-access) - [Medication Access](https://www.gilead.com/medicines/medication-access/overview) - [U.S. Patient Access](https://www.gilead.com/medicines/medication-access/us-patient-access) - [Managed Access](https://www.gilead.com/medicines/medication-access/managed-access) - [Authorized Distributors](https://www.gilead.com/medicines/authorized-distributors) - [Responsibility](https://www.gilead.com/responsibility) - [Responsibility](https://www.gilead.com/responsibility/overview) - [ESG](https://www.gilead.com/responsibility/esg) - [ESG](https://www.gilead.com/responsibility/esg/overview) - [ESG Performance](https://www.gilead.com/responsibility/esg/esg-performance) - [ESG Focus Areas](https://www.gilead.com/responsibility/esg/esg-focus-areas) - [ESG Frameworks and Reporting](https://www.gilead.com/responsibility/esg/esg-frameworks-and-reporting) - [Sustainability](https://www.gilead.com/responsibility/sustainability) - [Sustainability](https://www.gilead.com/responsibility/sustainability/overview) - [Sustainability Focus Areas](https://www.gilead.com/responsibility/sustainability/sustainability-focus-areas) - [Health Equity](https://www.gilead.com/responsibility/health-equity) - [Giving@Gilead](https://www.gilead.com/responsibility/giving-at-gilead) - [Giving@Gilead](https://www.gilead.com/responsibility/giving-at-gilead/overview) - [Corporate Giving](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving) - [Corporate Giving](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/overview) - [Strategic Initiatives](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives) - [Strategic Initiatives](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/overview) - [All4Liver](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/all4liver) - [Asia Pacific Rainbow Grant](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/asia-pacific-rainbow-grant) - [COMPASS Initiative](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/compass-initiative) - [HepConnect](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/hepconnect) - [HIV Age Positively](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/hiv-age-positively) - [RADIAN](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/radian) - [Setting the P.A.C.E.- Prevention, Arts and Advocacy, Community, Education](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/setting-the-pace) - [Gilead Oncology Grant](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/gilead-oncology-grant) - [Toward Health Equity for Black People Impacted by TNBC](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/toward-health-equity-for-black-people-impacted-by-tnbc) - [TRANScend](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/transcend) - [Zeroing In: Ending the HIV Epidemic](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/zeroing-in-ending-the-hiv-epidemic) - [How to Apply for Funding](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding) - [How to Apply for Funding](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/overview) - [Giving in Africa](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-africa) - [Giving in Asia](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-asia) - [Giving in Australia](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-australia) - [Giving in Europe & the Middle East](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-europe-and-the-middle-east) - [Giving in Latin America & the Caribbean](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-latin-america-and-the-caribbean) - [Giving in North America](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-north-america) - [Terms & Conditions](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/terms-and-conditions) - [FAQs](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/faqs) - [Gilead Foundation](https://www.gilead.com/responsibility/giving-at-gilead/gilead-foundation) - [Gilead Foundation](https://www.gilead.com/responsibility/giving-at-gilead/gilead-foundation/overview) - [Creating Possible Fund](https://www.gilead.com/responsibility/giving-at-gilead/gilead-foundation/creating-possible-fund) - [Building Community Donations](https://www.gilead.com/responsibility/giving-at-gilead/gilead-foundation/building-community-donations) - [Global Health and Access](https://www.gilead.com/responsibility/global-health-and-access) - [Global Health and Access](https://www.gilead.com/responsibility/global-health-and-access/overview) - [FOCUS](https://www.gilead.com/responsibility/global-health-and-access/focus) - [Access in Low- and Middle-Income Countries](https://www.gilead.com/responsibility/global-health-and-access/access-in-low--and-middle-income-countries) - [Access in Low- and Middle-Income Countries](https://www.gilead.com/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/overview) - [Access Strategy for Long-Acting PrEP](https://www.gilead.com/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/access-strategy-for-long-acting-prep) - [Invasive Fungal Infections](https://www.gilead.com/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/invasive-fungal-infection) - [Access Partnerships](https://www.gilead.com/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/access-partnerships) - [Inclusion and Diversity](https://www.gilead.com/responsibility/inclusion-and-diversity) - [Inclusion and Diversity](https://www.gilead.com/responsibility/inclusion-and-diversity/overview) - [Employee Resource Groups](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups) - [Employee Resource Groups](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/overview) - [ADAPT](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/adapt) - [GAIN](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/gain) - [Gileados](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/gileados) - [GLOBE](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/globe) - [GVET](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/gvet) - [Pride Alliance](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/pride-alliance) - [Women at Gilead](https://www.gilead.com/responsibility/inclusion-and-diversity/employee-resource-groups/women-at-gilead) - [Medical Education](https://www.gilead.com/responsibility/medical-education) - [Stories](https://www.gilead.com/stories) - [Company](https://www.gilead.com/company) - [Company](https://www.gilead.com/company/overview) - [Leadership](https://www.gilead.com/company/leadership) - [View All Leaders](https://www.gilead.com/company/leadership/overview) - [Daniel O’Day](https://www.gilead.com/company/leadership/daniel-oday) - [Andrew Dickinson](https://www.gilead.com/company/leadership/andrew-dickinson) - [Stacey Ma](https://www.gilead.com/company/leadership/stacey-ma) - [Dietmar Berger, MD, PhD](https://www.gilead.com/company/leadership/dietmar-berger) - [Flavius Martin, MD](https://www.gilead.com/company/leadership/flavius-martin) - [Jyoti Mehra](https://www.gilead.com/company/leadership/jyoti-mehra) - [Johanna Mercier](https://www.gilead.com/company/leadership/johanna-mercier) - [Cindy Perettie](https://www.gilead.com/company/leadership/cindy-perettie) - [Keeley Cain Wettan](https://www.gilead.com/company/leadership/keeley-wettan) - [Board of Directors](https://www.gilead.com/company/board-of-directors) - [View All Directors](https://www.gilead.com/company/board-of-directors/overview) - [Daniel O’Day](https://www.gilead.com/company/board-of-directors/daniel-oday) - [Jacqueline K. Barton, PhD](https://www.gilead.com/company/board-of-directors/jacqueline-barton) - [Jeffrey A. Bluestone, PhD](https://www.gilead.com/company/board-of-directors/jeffrey-bluestone) - [Sandra J. Horning, MD](https://www.gilead.com/company/board-of-directors/sandra-horning) - [Kelly A. Kramer](https://www.gilead.com/company/board-of-directors/kelly-kramer) - [Ted W. Love, MD](https://www.gilead.com/company/board-of-directors/ted-love) - [Harish Manwani](https://www.gilead.com/company/board-of-directors/harish-manwani) - [Javier J. Rodriguez](https://www.gilead.com/company/board-of-directors/javier-rodriguez) - [Anthony Welters](https://www.gilead.com/company/board-of-directors/anthony-welters) - [Board Governance and Committees](https://www.gilead.com/company/board-governance-and-committees) - [Media](https://www.gilead.com/company/media) - [Ethics and Compliance](https://www.gilead.com/company/ethics-and-compliance) - [Policies and Procedures](https://www.gilead.com/company/policies-and-procedures) - [Policies and Procedures](https://www.gilead.com/company/policies-and-procedures/overview) - [AI Principles](https://www.gilead.com/company/policies-and-procedures/ai-principles) - [Disclosures](https://www.gilead.com/company/disclosures) - [U.S. Public Policy Engagement](https://www.gilead.com/company/us-public-policy-engagement) - [U.S. Public Policy Engagement](https://www.gilead.com/company/us-public-policy-engagement/overview) - [Political Contributions Archives](https://www.gilead.com/company/us-public-policy-engagement/political-contributions-archives) - [Investing in the U.S.](https://www.gilead.com/company/investing-in-the-us) - [Supplier Information](https://www.gilead.com/company/supplier-information) - [Supplier Information](https://www.gilead.com/company/supplier-information/overview) - [Supplier Enablement Resources: SAP Ariba](https://www.gilead.com/company/supplier-information/supplier-enablement-resources-sap-ariba) - [Supplier Inclusion](https://www.gilead.com/company/supplier-information/supplier-inclusion) - [Annual Impact Reports](https://www.gilead.com/company/annual-impact-reports) - [Awards and Recognition](https://www.gilead.com/company/awards-and-recognition) - [U.S. Locations](https://www.gilead.com/company/us-locations) - [Careers](https://www.gilead.com/careers) - [Careers](https://www.gilead.com/careers/overview) - [Life at Gilead](https://www.gilead.com/careers/life-at-gilead) - [Life at Gilead](https://www.gilead.com/careers/life-at-gilead/overview) - [Inclusion and Diversity in Hiring](https://www.gilead.com/careers/life-at-gilead/inclusion-and-diversity-in-hiring) - [Opportunities](https://www.gilead.com/careers/opportunities) - [Opportunities](https://www.gilead.com/careers/opportunities/overview) - [Early Career Opportunities](https://www.gilead.com/careers/opportunities/early-career-opportunities) - [Early Career Opportunities](https://www.gilead.com/careers/opportunities/early-career-opportunities/overview) - [Gilead Internship Program](https://www.gilead.com/careers/opportunities/early-career-opportunities/gilead-internship-program) - [Postdoctoral fellowships](https://www.gilead.com/careers/opportunities/early-career-opportunities/postdoctoral-fellowships) - [Global Workforce](https://www.gilead.com/careers/global-workforce) - [Media](https://www.gilead.com/media) - [Investors](https://investors.gilead.com/) Search ``` ``` Search Hamber ![Gilead Logo](https://gilead.stylelabs.cloud/api/public/content/c77b5bddc2524cd1bcfe0d0d1288027f?v=a5ef68f5) # CREATING A HEALTHIER WORLD FOR ALL PEOPLE ##### We’re honored to be recognized for advancing health around the world—driven by breakthrough science, a culture where everyone belongs, and partnerships rooted in the communities we serve. [Learn more](https://www.gilead.com/company/awards-and-recognition). ![People working at Lab](https://gilead.stylelabs.cloud/api/public/content/4c4d88f08457464a9ab7f2a5cbd22d5b?v=9fbe234a)![Gilead\_Home\_Banner\_Dec\_15\_2025\_Mobile.png](https://gilead.stylelabs.cloud/api/public/content/db6c8fd7667b4799ad2246fe0c06955d?v=87130b38) ## Delivering Transformative Therapies and Advancing Health Equity Through innovation, we’re helping to build a healthier world for all people. [Learn More About Gilead](https://www.gilead.com/company) ![Medicines Offered Globally ](https://gilead.stylelabs.cloud/api/public/content/7457d41053dd4f9fae97c0e4ff93270c?v=400f31d9) 25+ Medicines Offered Globally ![HIV-and-Viral-Hepatitis](https://gilead.stylelabs.cloud/api/public/content/6d837fdd76624d5bb0e1f021be9e4734?v=6bddf3f9) 53 Clinical Programs Across Virology, Oncology and Inflammation ![Philanthropic Funder of HIV-Related Programs ](https://gilead.stylelabs.cloud/api/public/content/709f9f9997a14c8daa1d59176cf8f393?v=9636f0c8) \#1 Funder of Philanthropic HIV Programs in the U.S. ![Four Gilead researchers in a lab.](https://gilead.stylelabs.cloud/api/public/content/bb257175bfae4bf88be1cd7439fa619f?v=b60cb4d9)![Four Gilead researchers in a lab.](https://gilead.stylelabs.cloud/api/public/content/3a35452a55a14b0099fe5dec989d4609?v=559e1037) ## Using Science to Improve the Lives of People and Communities We invest in world-class science to combat the world's most serious diseases. [Explore Science](https://www.gilead.com/science) ## A Strong Pipeline Spanning Three Therapeutic Areas We have a deep, diverse pipeline across Virology, Oncology and Inflammation. [View Our Pipeline](https://www.gilead.com/science/pipeline) ![A Gilead scientist smiling](https://gilead.stylelabs.cloud/api/public/content/78bb07c0feba4a1ba3d0402569b69927?v=e51d4bc1)![A Gilead scientist smiling](https://gilead.stylelabs.cloud/api/public/content/7c378c48a4c641bf8f5c7917d02e5327?v=1228dce1) [Virology ![Virology logo](https://gilead.stylelabs.cloud/api/public/content/a377511be5e34ac784b5acd7139ed0e5?v=32be3eef)](https://www.gilead.com/science/therapeutic-areas/virology) [Oncology ![Oncology icon](https://gilead.stylelabs.cloud/api/public/content/bb4128c460f64f5aadded9bf7c04b770?v=97659d8e)](https://www.gilead.com/science/therapeutic-areas/oncology) [Inflammation ![Inflammation icon](https://gilead.stylelabs.cloud/api/public/content/01b274cab814448c9b37a3cd6d41285a?v=2c54e11c)](https://www.gilead.com/science/therapeutic-areas/inflammation) [View All Therapeutic Areas](https://www.gilead.com/science/therapeutic-areas) Stories@Gilead Follow our journey to create a healthier world for all people No story to list Loading Results... [View Stories@Gilead](https://www.gilead.com/stories) ## An Inclusive Workplace Where We All Can Make an Impact Gilead employees work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work. [Explore Careers at Gilead](https://www.gilead.com/careers) ![Five people standing and smiling](https://gilead.stylelabs.cloud/api/public/content/5beee38dbec7460581db202870c4950f?v=f24d33e4)![Five people standing and smiling](https://gilead.stylelabs.cloud/api/public/content/cef297623ee04153bd980cb3e81ea518?v=47c946dd) ## News Some of the content on this page is not intended for users outside the U.S. [View News](https://www.gilead.com/news) Loading Results... Investors ## Driven by Purpose, Delivering Life-Changing Therapies ### Resources for Investors [Investor Relations](https://investors.gilead.com/overview/default.aspx) [Events and Presentations](https://investors.gilead.com/events-and-presentations/default.aspx) [Stock Information](https://investors.gilead.com/stock-info/default.aspx) ![a Gilead building](https://gilead.stylelabs.cloud/api/public/content/8b602d133f9a49908203ac4dfd533e9b?v=6bd18196)![Gilead Building](https://gilead.stylelabs.cloud/api/public/content/c139780057a54567a3b422751412d78d?v=02306872) ![All-Pages-Gilead-logo](https://gilead.stylelabs.cloud/api/public/content/89749f3b535e4eebb8ae07c8e9607b17?v=bf06f14e) This is our global website, intended for visitors seeking information on Gilead’s worldwide business. Some content on this site is not intended for people outside the United States. Visit our [Global Operations](https://www.gilead.com/global-operations) page for links to our international corporate websites. ### QUICK LINKS - [Investors](https://investors.gilead.com/overview/default.aspx) - [Find a Trial](https://www.gileadclinicaltrials.com/) - [Pipeline](https://www.gilead.com/science/pipeline) - [Search for Jobs](https://gilead.yello.co/job_boards/v42vD4vKxb3AkKvV93YsrQ) - [News](https://www.gilead.com/news) - [Stories@Gilead](https://www.gilead.com/stories) ### GET IN TOUCH - [Contact Us](https://www.gilead.com/contact-us) - [Report an Adverse Event](https://www.gilead.com/contact-us/report-an-adverse-event) - [Medical Information](https://www.askgileadmedical.com/) - [Partnership Request](https://www.gilead.com/contact-us/partnership-request) ### LEGAL - [Modern Slavery Act Statement](https://www.gilead.com/-/media/files/pdfs/company/policies-and-disclosures/modern-slavery-statement.pdf) - [Public Policy Engagement](https://www.gilead.com/company/us-public-policy-engagement) - [Social Media Guidelines](https://www.gilead.com/social-media-guidelines) - [Privacy Statement](https://www.gilead.com/privacy-statements) - [Consumer Health Data Privacy Policy](https://www.gilead.com/privacy-statements/consumer-health-data-privacy-policy) - [Terms of Use](https://www.gilead.com/terms-of-use) - [Cookie Statement](https://www.gilead.com/cookie-statement) *** © 1996-2026 Gilead Sciences, Inc. All rights reserved. [Global Operations](https://www.gilead.com/global-operations) [Sitemap](https://www.gilead.com/sitemap)
Readable Markdown	## Delivering Transformative Therapies and Advancing Health Equity Through innovation, we’re helping to build a healthier world for all people. [Learn More About Gilead](https://www.gilead.com/company) ![Medicines Offered Globally ](https://gilead.stylelabs.cloud/api/public/content/7457d41053dd4f9fae97c0e4ff93270c?v=400f31d9) 25+ Medicines Offered Globally ![HIV-and-Viral-Hepatitis](https://gilead.stylelabs.cloud/api/public/content/6d837fdd76624d5bb0e1f021be9e4734?v=6bddf3f9) 53 Clinical Programs Across Virology, Oncology and Inflammation ![Philanthropic Funder of HIV-Related Programs ](https://gilead.stylelabs.cloud/api/public/content/709f9f9997a14c8daa1d59176cf8f393?v=9636f0c8) \#1 Funder of Philanthropic HIV Programs in the U.S. ![Four Gilead researchers in a lab.](https://gilead.stylelabs.cloud/api/public/content/bb257175bfae4bf88be1cd7439fa619f?v=b60cb4d9)![Four Gilead researchers in a lab.](https://gilead.stylelabs.cloud/api/public/content/3a35452a55a14b0099fe5dec989d4609?v=559e1037) ## Using Science to Improve the Lives of People and Communities We invest in world-class science to combat the world's most serious diseases. [Explore Science](https://www.gilead.com/science) ## A Strong Pipeline Spanning Three Therapeutic Areas We have a deep, diverse pipeline across Virology, Oncology and Inflammation. [View Our Pipeline](https://www.gilead.com/science/pipeline) ![A Gilead scientist smiling](https://gilead.stylelabs.cloud/api/public/content/78bb07c0feba4a1ba3d0402569b69927?v=e51d4bc1)![A Gilead scientist smiling](https://gilead.stylelabs.cloud/api/public/content/7c378c48a4c641bf8f5c7917d02e5327?v=1228dce1) Stories@Gilead Follow our journey to create a healthier world for all people No story to list Loading Results... ## An Inclusive Workplace Where We All Can Make an Impact Gilead employees work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work. [Explore Careers at Gilead](https://www.gilead.com/careers) ![Five people standing and smiling](https://gilead.stylelabs.cloud/api/public/content/5beee38dbec7460581db202870c4950f?v=f24d33e4)![Five people standing and smiling](https://gilead.stylelabs.cloud/api/public/content/cef297623ee04153bd980cb3e81ea518?v=47c946dd) ## News Some of the content on this page is not intended for users outside the U.S. [View News](https://www.gilead.com/news) Loading Results... Investors ## Driven by Purpose, Delivering Life-Changing Therapies ![a Gilead building](https://gilead.stylelabs.cloud/api/public/content/8b602d133f9a49908203ac4dfd533e9b?v=6bd18196)![Gilead Building](https://gilead.stylelabs.cloud/api/public/content/c139780057a54567a3b422751412d78d?v=02306872)
Shard	57 (laksa)
Root Hash	703463787215412657
Unparsed URL	com,gilead!www,/ s443